Skip to content
Riskpilot
← Back to search
Sign in
Get full access
CiVi Biopharma ApS
APS
In liquidation
Advertising protection
CVR 38027794
Sundkrogsgade 21, 2100
København Ø
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2016 · 9 years old
1 employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
CiVi Biopharma ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
1M
2M
3M
5M
4M
2020
4M
2021
4M
2022
4M
2023
1M
2024
EBITDA
DKK millions
1M
1M
0M
-1M
-1M
1M
2020
0M
-100%
2021
0M
0%
2022
0M
0%
2023
-1M
-100%
2024
Income statement
DKK thousands
Item
2020
2021
2022
2023
2024
Gross profit
4.485
4.036
3.530
3.502
611
Staff expenses
-3.970
-3.583
-3.100
-3.100
-2.075
EBITDA
515
453
430
402
-1.465
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
515
453
430
402
-1.465
Net financials
-12
-11
-11
-2.200
80
Profit before tax
503
442
419
-1.798
-1.385
Tax
111
98
93
89
26
Net profit
392
344
326
-1.887
-1.410
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
2024
Total assets
4.114
4.332
3.948
2.285
128
Equity
2.705
3.049
3.375
1.488
78
Long-term debt
0
0
0
0
0
Short-term debt
1.409
1.283
572
797
50
Total debt
1.409
1.283
572
797
50
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-239.9%
This company
2020
2024
Equity ratio
60.9%
This company
38.2%
Market median
+59% vs market
2020
2024
Return on equity
-1812.3%
This company
18.4%
Market median
-9949% vs market
2020
2024
Net profit margin (of gross profit)
-231.0%
This company
2020
2024
Asset turnover (of gross profit)
4.78×
This company
2020
2024
Debt / equity
0.64×
This company
0.62×
Market median
+3% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
More on CiVi Biopharma ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
